Sweden· SE-20130705000051
Gemkabi 38 mg/ml Koncentrat till infusionsvätska, lösning
A medicinal product containing gemcitabine, registered in Sweden by Fresenius Kabi AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Gemcitabine
- Manufacturer
- Fresenius Kabi AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20130705000051
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gemcitabine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGemcitabine EG 38 mg/mlEG
- FinlandGemcitabin PfizerPfizer PFE Finland Oy
- CzechiaGEMCITABINE KABIFresenius Kabi s.r.o., Praha
- PolandGemcitabine KabiFresenius Kabi Polska Sp. z o.o.
- IrelandGemcitabine 38 mg/ml Concentrate for Solution for InfusionFresenius Kabi Deutschland GmbH
- IcelandGemkabiFresenius Kabi AB
- NorwayGemkabiFRESENIUS KABI NORGE AS
- United KingdomGemcitabine 1.2g/120ml infusion bagsSun Pharma UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Gemcitabin Accord, Gemcitabin Ebewe
- Belgium · Gemcitabin Sandoz, Gemcitabin Sun
- Bulgaria · Гемсол, Гемцитабин Акорд
- Cyprus · Gemcitabine Accord, Gemnil
- Czechia · Gemcitabin Ebewe, Gemcitabin Sun
- Germany · Bendacitabin, Gemci-Cell
- Denmark · Gemcitabin "sandoz", Gemcitabin Accord
- Estonia · Gemcitabine Accord, Gemcitabine Kabi
- Spain · Gemcitabina Accord, Gemcitabina Aurovitas Spain
- Finland · Gemcitabin Accord, Gemcitabin Sandoz
- France · Gemcitabine Accord, Gemcitabine Arrow
- United Kingdom (Northern Ireland) · Gemcitabine Accord Healthcare, Gemcitabine Ennogen Ip
- Greece · Demozar, Gemcipen
- Croatia · Gemcitabin Accord, Gemcitabin Sandoz
- Hungary · Gemcitabin Kabi, Gemcitabine Accord
- Ireland · Gemcitabine, Gemcitabine Accord Healthcare
- Iceland · Gemcitabin Wh, Gemkabi
- Italy · Gemcitabina Accord, Gemcitabina Aurobindo Pharma Italia
- Lithuania · Gemcitabine Accord, Gemcitabine Kabi
- Luxembourg · Gemcitabine Eg, Gemcitabine Eugia
- Latvia · Gemcitabine Accord, Gemcitabine Kabi
- Malta · Gemcitabine Pfizer Hellas, Gemnil
- Netherlands · Gemcitabine Accord, Gemcitabine Fresenius Kabi
- Norway · Gemcitabin Sandoz, Gemcitabin Sun
- Poland · Gemcitabine Kabi, Gemcitabinum Accord
- Portugal · Gemcit, Gemcitabina Accord
- Romania · Gemcitabină Accord, Gemcitabina Kabi
- Slovenia · Gemcitabin Accord, Gemcitabin Kabi
- Slovakia · Gemcitabín Sun, Gemcitabine Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/57dabfc8-ca0f-450d-aab7-77119536acd7 GET /v1/drugs/57dabfc8-ca0f-450d-aab7-77119536acd7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20130705000051",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20130705000051",
"product_doc_link": "https://docetp.mpa.se/LMF/Gemkabi%20concentrate%20for%20solution%20for%20infusion%20SmPC_09001bee807a36a3.pdf"
}See everything about gemcitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.